372 related articles for article (PubMed ID: 18551626)
1. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice.
Bruce-Keller AJ; Turchan-Cholewo J; Smart EJ; Geurin T; Chauhan A; Reid R; Xu R; Nath A; Knapp PE; Hauser KF
Glia; 2008 Oct; 56(13):1414-27. PubMed ID: 18551626
[TBL] [Abstract][Full Text] [Related]
2. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
[TBL] [Abstract][Full Text] [Related]
3. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
[TBL] [Abstract][Full Text] [Related]
4. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
El-Hage N; Bruce-Keller AJ; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2008 Dec; 3(4):275-85. PubMed ID: 18815890
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.
Suzuki M; El-Hage N; Zou S; Hahn YK; Sorrell ME; Sturgill JL; Conrad DH; Knapp PE; Hauser KF
Mol Neurodegener; 2011 Nov; 6():78. PubMed ID: 22093090
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.
Hauser KF; Hahn YK; Adjan VV; Zou S; Buch SK; Nath A; Bruce-Keller AJ; Knapp PE
Glia; 2009 Jan; 57(2):194-206. PubMed ID: 18756534
[TBL] [Abstract][Full Text] [Related]
7. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.
Gurwell JA; Nath A; Sun Q; Zhang J; Martin KM; Chen Y; Hauser KF
Neuroscience; 2001; 102(3):555-63. PubMed ID: 11226693
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
El-Hage N; Wu G; Wang J; Ambati J; Knapp PE; Reed JL; Bruce-Keller AJ; Hauser KF
Glia; 2006 Jan; 53(2):132-46. PubMed ID: 16206161
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of enteric neurons to morphine by HIV-1 Tat protein.
Fitting S; Ngwainmbi J; Kang M; Khan FA; Stevens DL; Dewey WL; Knapp PE; Hauser KF; Akbarali HI
Neurogastroenterol Motil; 2015 Apr; 27(4):468-80. PubMed ID: 25703354
[TBL] [Abstract][Full Text] [Related]
10. Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
Fitting S; Scoggins KL; Xu R; Dever SM; Knapp PE; Dewey WL; Hauser KF
Eur J Pharmacol; 2012 Aug; 689(1-3):96-103. PubMed ID: 22659585
[TBL] [Abstract][Full Text] [Related]
11. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.
Fitting S; Xu R; Bull C; Buch SK; El-Hage N; Nath A; Knapp PE; Hauser KF
Am J Pathol; 2010 Sep; 177(3):1397-410. PubMed ID: 20651230
[TBL] [Abstract][Full Text] [Related]
12. Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.
Zou S; Fitting S; Hahn YK; Welch SP; El-Hage N; Hauser KF; Knapp PE
Brain; 2011 Dec; 134(Pt 12):3616-31. PubMed ID: 22102648
[TBL] [Abstract][Full Text] [Related]
13. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF
Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704
[TBL] [Abstract][Full Text] [Related]
14. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.
El-Hage N; Wu G; Ambati J; Bruce-Keller AJ; Knapp PE; Hauser KF
J Neuroimmunol; 2006 Sep; 178(1-2):9-16. PubMed ID: 16831471
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.
Leibrand CR; Paris JJ; Jones AM; Masuda QN; Halquist MS; Kim WK; Knapp PE; Kashuba ADM; Hauser KF; McRae M
J Neurovirol; 2019 Aug; 25(4):560-577. PubMed ID: 31102185
[TBL] [Abstract][Full Text] [Related]
16. Morphine enhances Tat-induced activation in murine microglia.
Bokhari SM; Yao H; Bethel-Brown C; Fuwang P; Williams R; Dhillon NK; Hegde R; Kumar A; Buch SJ
J Neurovirol; 2009 May; 15(3):219-28. PubMed ID: 19462331
[TBL] [Abstract][Full Text] [Related]
17. Ligand-gated purinergic receptors regulate HIV-1 Tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures.
Sorrell ME; Hauser KF
J Neuroimmune Pharmacol; 2014 Mar; 9(2):233-44. PubMed ID: 24158495
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes.
Zhou BY; Liu Y; Kim Bo; Xiao Y; He JJ
Mol Cell Neurosci; 2004 Nov; 27(3):296-305. PubMed ID: 15519244
[TBL] [Abstract][Full Text] [Related]
19. Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.
Fitting S; Stevens DL; Khan FA; Scoggins KL; Enga RM; Beardsley PM; Knapp PE; Dewey WL; Hauser KF
J Pharmacol Exp Ther; 2016 Jan; 356(1):96-105. PubMed ID: 26542403
[TBL] [Abstract][Full Text] [Related]
20. Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse.
Lapierre J; Rodriguez M; Ojha CR; El-Hage N
J Neuroimmune Pharmacol; 2018 Sep; 13(3):355-370. PubMed ID: 29752681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
